DRTS
Alpha Tau Medical focuses on developing and commercializing Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The company specializes in intratumoral radiotherapeutics, delivering highly potent alpha radiation directly within tumors to spare surrounding healthy tissue. Based on its research origins and clinical programs, Alpha Tau Medical emphasizes oncology applications across multiple cancer types and is actively conducting clinical trials. The technology originated at Tel Aviv University and the company operates in the field of targeted radiotherapy for cancer.”
No recent news for this company.
No recent deals for this company.